Targeted pulmonary drug delivery in coronavirus disease (COVID-19) therapy: A patient-specific in silico study based on magnetic nanoparticles-coated microcarriers adhesion

Since the beginning of the COVID-19 pandemic, nearly most confirmed cases develop respiratory syndromes. Using targeted drug delivery by microcarriers is one of the most important noteworthy methods for delivering drugs to the involved bronchi. This study aims to investigate the performance of a dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebrahimi, Sina, Shamloo, Amir, Alishiri, Mojgan, Mofrad, Yasaman Mozhdehbakhsh, Akherati, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459545/
https://www.ncbi.nlm.nih.gov/pubmed/34563616
http://dx.doi.org/10.1016/j.ijpharm.2021.121133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459545/
https://www.ncbi.nlm.nih.gov/pubmed/34563616
http://dx.doi.org/10.1016/j.ijpharm.2021.121133

Ejemplares similares